» Articles » PMID: 6418722

Biosynthesis of C30 to C56 Fatty Acids by an Extract of Mycobacterium Tuberculosis H37Ra

Overview
Journal J Bacteriol
Specialty Microbiology
Date 1984 Jan 1
PMID 6418722
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

A 10,800 X g supernatant fraction from disrupted cells of Mycobacterium tuberculosis H37Ra was incubated with [2-14C]malonate to produce labeled long-chain fatty acids upon saponification. These acids were derivatized to the p-bromophenacyl ester and separated into the nonmycolic saturated, monounsaturated, and multiunsaturated esters by argentation thin-layer chromatography. Each of these fractions was then analyzed by high-performance liquid chromatography by using a C18-bonded silica cartridge and a mobile phase of a linear gradient of 0 to 70% p-dioxane in acetonitrile. The results showed that the cell-free system is able to synthesize both saturated and monounsaturated fatty acids of the sizes C30 to C40 and C48 to C56. This latter series was strikingly similar to meromycolic acid, a putative precursor of mycolic acid. When acetate or oleate was used as the labeled substrate, the major products were no longer than C32. When palmitate was used as the labeled substrate, the saturated acids ranged in size from C18 to C32, whereas the monounsaturated products contained C18, C26 to C30 and C40 fatty acids. Fatty acids greater than C40 were also detected. When methyl-labeled S-adenosyl-L-methionine was used as the substrate, the methyl group was incorporated into short-chain and C48 to C56 fatty acids. Unlabeled malonyl-coenzyme A was included in all of these reactions. This cell-free system was not able to synthesize mycolic acid (final product) or its keto derivative (intermediate product). However, since the meromycolate-like C48 to C56 fatty acids were synthesized, we suggest that the present system is able to take the synthesis to a point before the alpha-alkyl condensation reaction.

Citing Articles

HadD, a novel fatty acid synthase type II protein, is essential for alpha- and epoxy-mycolic acid biosynthesis and mycobacterial fitness.

Lefebvre C, Boulon R, Ducoux M, Gavalda S, Laval F, Jamet S Sci Rep. 2018; 8(1):6034.

PMID: 29662082 PMC: 5902629. DOI: 10.1038/s41598-018-24380-5.


Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis.

Takayama K, Wang C, Besra G Clin Microbiol Rev. 2005; 18(1):81-101.

PMID: 15653820 PMC: 544180. DOI: 10.1128/CMR.18.1.81-101.2005.


A mutant of Mycobacterium smegmatis defective in the biosynthesis of mycolic acids accumulates meromycolates.

Liu J, Nikaido H Proc Natl Acad Sci U S A. 1999; 96(7):4011-6.

PMID: 10097154 PMC: 22411. DOI: 10.1073/pnas.96.7.4011.


Antimycobacterial action of thiolactomycin: an inhibitor of fatty acid and mycolic acid synthesis.

Slayden R, Lee R, Armour J, Cooper A, Orme I, Brennan P Antimicrob Agents Chemother. 1996; 40(12):2813-9.

PMID: 9124847 PMC: 163628. DOI: 10.1128/AAC.40.12.2813.


Determination of the primary target for isoniazid in mycobacterial mycolic acid biosynthesis with Mycobacterium aurum A+.

Wheeler P, Anderson P Biochem J. 1996; 318 ( Pt 2):451-7.

PMID: 8809032 PMC: 1217642. DOI: 10.1042/bj3180451.


References
1.
Winder F, Brennan P, Ratledge C . Synthesis of fatty acids by extracts of mycobacteria and the absence of inhibition by isoniazid. Biochem J. 1964; 93(3):635-40. PMC: 1214022. DOI: 10.1042/bj0930635. View

2.
KANETSUNA F . Chemical analyses of mycobacterial cell walls. Biochim Biophys Acta. 1968; 158(1):130-43. DOI: 10.1016/0304-4165(68)90080-9. View

3.
Lederer E . The mycobacterial cell wall. Pure Appl Chem. 1971; 25(1):135-65. DOI: 10.1351/pac197125010135. View

4.
Takayama K, Schnoes H, Armstrong E, Boyle R . Site of inhibitory action of isoniazid in the synthesis of mycolic acids in Mycobacterium tuberculosis. J Lipid Res. 1975; 16(4):308-17. View

5.
Bloch K . Control mechanisms for fatty acid synthesis in Mycobacterium smegmatis. Adv Enzymol Relat Areas Mol Biol. 1977; 45:1-84. DOI: 10.1002/9780470122907.ch1. View